EDGAR Filing Documents for 0001213900-18-010023

Form 1-A/A - Offering Statement [Regulation A]: [Amend]

SEC Accession No. 0001213900-18-010023

Filing Date

2018-08-01

Accepted

2018-08-01 15:00:28

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	1-A/A
1		primary_doc.xml	1-A/A	19576
2	PRELIMINARY OFFERING CIRCULAR	f1a2018a3_2020genesystems.htm	PART II AND III	953890
3	AMENDMENT TO ISSUER AGREEMENT, EFFECTIVE JULY 31, 2018, BETWEEN 20/20 GENESYSTEM	f1a2018a3ex1-2_2020genesys.htm	EX1A-1 UNDR AGMT	22419
4	FORM OF SUBSCRIPTION AGREEMENT	f1a2018a3ex4_2020genesys.htm	EX1A-4 SUBS AGMT	80950
5	CONSENT OF DBBMCKENNON	f1a2018a3ex11-1_2020genesys.htm	EX1A-11 CONSENT	2653
6	OPINION OF BEVILACQUA PLLC	f1a2018a3ex12-1_2020genesys.htm	EX1A-12 OPN CNSL	11050
7	GRAPHIC	image_002.jpg	GRAPHIC	4538
8	GRAPHIC	image_003.jpg	GRAPHIC	1104
9	GRAPHIC	img_01.jpg	GRAPHIC	28636
10	GRAPHIC	img_02.jpg	GRAPHIC	29950
11	GRAPHIC	img_03.jpg	GRAPHIC	17497
12	GRAPHIC	img_04.jpg	GRAPHIC	64440
13	GRAPHIC	img_05.jpg	GRAPHIC	70140
14	GRAPHIC	img_06.jpg	GRAPHIC	35016
	Complete submission text file	0001213900-18-010023.txt		1438900

Mailing Address 9430 KEY WEST AVE. ROCKVILLE MD 20850

Business Address 9430 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 2404536339

20/20 GeneSystems, Inc. (Filer) CIK: 0001139685 (see all company filings)